Sign Up to like & get
recommendations!
0
Published in 2021 at "Small methods"
DOI: 10.1002/smtd.202101047
Abstract: Cisplatin has been used as standard regimen for hepatocellular carcinoma (HCC), but its therapeutic efficacy is greatly limited by the drug resistance. Cisplatin alone cannot achieve an ideal therapeutic outcome. Herein, a dual threat hybrid…
read more here.
Keywords:
iodo click;
reaction;
chemotherapy;
cdt ... See more keywords